[General Articles] Altered Protein Acetylation in Polyglutamine Diseases

E-ISSN： 1875-533x|10|23|2577-2587

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.23, 2003-12, pp. : 2577-2587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2543-2555

Bentham Science Publishers

Access to resources Recommend Favorite

Towards the Treatment of Polyglutamine Diseases: The Modulatory Role of Protein Context

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3058-3068

Bentham Science Publishers

Access to resources Recommend Favorite

Diseases Originating from Altered Protein Quality Control in the Endoplasmic Reticulum

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1639-1652

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of cell death in polyglutamine expansion diseases

By Lipinski M.M. Yuan J.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

Transcriptional Dysregulation: A Therapeutic Target for Polyglutamine Diseases

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-06 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite